Noninvasive Vagal Nerve Stimulation Trial
30
about 9 months
25–65
1 site in NY
What this study is about
This trial is testing whether remotely supervised transcutaneous auricular vagus nerve stimulation (taVNS), transcutaneous cervical vagus nerve stimulation (tcVNS), or transcranial direct current stimulation (tDCS) can help reduce symptoms in people with multiple sclerosis. The goal of this pilot trial is to determine if these treatments are feasible and may improve symptom reduction, as measured by self-reported outcomes and heart rate variability.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Remotely Supervised Transcranial Direct Current Stimulation (RS - tDCS)
- 2.Use Remotely Supervised Transcutaneous Auricular Vagus Nerve Stimulation (RS - taVNS)
- 3.Use Remotely Supervised Transcutaneous Cervical Vagus Nerve Stimulation (RS - tcVNS)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Change in Composite Autonomic Symptom Score-31 (COMPASS-31) Score, Change in General Anxiety Disorder (GAD-7) Score, Change in Heart Rate Variability (HRV), Change in Memorial Symptom Assessment Scale (MSAS) Score, Change in PROMIS Fatigue - Short Form 7a Score, Change in PROMIS Pain Intensity - Short Form 3a Score, Change in Patient Health Questionnaire (PHQ-9) Score, Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance - Short Form Score
therapeutic
Neurology